UPDATE: AngioDynamics (ANGO) Tops Q3 EPS by 1c; Cuts FY EPS Outlook
(Updated - April 7, 2016 4:04 PM EDT)
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $87.4 million versus the consensus estimate of $85.07 million.
The company sees FY15 EPS of $0.54 - $0.58, from $0.59 - $0.63 prior and the consensus of $0.60.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.